Table 1 Clinical, demographic characteristics and systemic disease activity indexes of psoriatic arthritis patients
Knee | Disease duration (years) | Gonarthritis duration (years) | Treatment at study entry | ESR | CRP | DAS | mRAI | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PRE | POST | PRE | POST | PRE | POST | PRE | POST | ||||
1 | 10.3 | 10.3 | MTX; PN | 46.4 | 88.4 | 1.78 | 0.33 | 3.21 | 3.42 | 8 | 8 |
2 | 8.4 | 6.4 | PN;MTX;CSA;E | 40.3 | 29.0 | 2.77 | 0.72 | 3.44 | 3.33 | 12 | 12 |
3 | 12.5 | 10.5 | PN | 23.2 | 22.2 | 0.53 | 0.02 | 2.33 | 1.25 | 3 | 0 |
4 | 8.6 | 8.6 | LEF;E | 72.5 | 33.8 | 0.56 | 0.56 | 2.78 | 2.59 | 4 | 4 |
5 | 22 | 5.7 | PN | 12.0 | 13.0 | 0.85 | 0.53 | 2.88 | 2.47 | 6 | 5 |
6 | 11 | 11 | MTX | 15.6 | 22.7 | 0.10 | 0.00 | 2.69 | 3.00 | 7 | 9 |
7 | 9 | 9 | SSZ | 15.0 | 11.0 | 0.66 | 0.39 | 3.18 | 2.42 | 12 | 5 |
8 | 6.5 | 4.3 | MTX; PN; E | 6.0 | 9.9 | 0.32 | 0.80 | 2.65 | 1.87 | 10 | 2 |
9 | 4 | 3.5 | MTX; SSZ | 18.1 | 3.6 | 2.93 | 0.24 | 2.52 | 0.71 | 5 | 0 |
10 | 9 | 15 | CSA;PN; E | 30.0 | 20.0 | 0.00 | 0.00 | 3.01 | 2.40 | 2 | 1 |
11 | 4.8 | 4.5 | MTX;CSA | 29.4 | 25.2 | 0.08 | 0.08 | 2.48 | 1.89 | 4 | 1 |
12 | 2.5 | 2.5 | MTX; PN | 14.3 | 6.8 | 0.70 | 0.20 | 3.97 | 3.40 | 20 | 18 |
13 | 8.5 | 2 | SSZ; MTX | 41.2 | 27.2 | 0.48 | 0.14 | 2.77 | 1.98 | 3 | 1 |
14 | 5.5 | 3.5 | SSZ | 13.6 | 2.2 | 0.26 | 0.26 | 3.22 | 0.75 | 9 | 0 |